What is nonacid reflux disease?


Upon completion of the study, the catheter is removed, and the data are downloaded and analyzed using dedicated software (Bioview Analysis, Sandhill Scientific Inc.). This is most likely the result of the limitation of conventional pH monitoring to separate patients in whom persistent symptoms are associated with reflux episodes with a pH above 4.0 (i.e., nonacid reflux) from those patients in whom symptoms are not associated with any type of reflux. In our experience evaluating the relationship between symptoms and acid reflux is as important as quantifying esophageal acid exposure.

Combined Multichannel Intraluminal Impedance pH Monitoring

Although there is an available drug that prevents relaxations (baclofen), it has side effects that are too frequent to be generally useful. Much attention is being directed at the development of drugs that prevent these relaxations without accompanying side effects. A third type of endoscopic treatment involves the injection of materials into the esophageal wall in the area of the LES. The injected material is intended to increase pressure in the LES and thereby prevent reflux.

In neonates, the high frequency of feeds results in a significant number of reflux episodes (detected as common cavities (CC)) not causing a drop in oesophageal pH across 4.18 GOR, gastro-oesophageal reflux. Bilitec is a monitoring system that can detect duodenogastro-oesophageal reflux (DGOR) by utilising the optical properties of bilirubin (table 1).36-41 Although Bilitec does not measure concentrations of duodenal components, a good correlation has been found between bilirubin content and the concentrations of pancreatic enzymes in aspirated refluxate, suggesting that bilirubin is a good tracer for duodenal components in the gastro-oesophageal refluxate.36,37 The working principle of Bilitec is that detection in the oesophageal lumen of any absorption near 450 nm suggests the presence of bilirubin, and therefore DGOR.

antireflux surgery [76]. In one earlier study comparing the clinical outcome of antireflux surgery between patients with erosive esophagitis and NERD, it was demonstrated that 91% versus 56% reported heartburn resolution, 24% versus 50% reported dysphagia after surgery, and 94% versus 79% were satisfied with surgery, respectively [76]. Visit our Acid Reflux / GERD category page for the latest news on this subject, or sign up to our newsletter to receive the latest updates on Acid Reflux / GERD.

In Asia, NERD is reported to affect different ethnic GERD populations such as 60% to 90% of the Chinese, 65% of the Indians, and 72% of the Malay [24]. While the association between apnea (a pause in breathing) and reflux in infants has been debated, there is some evidence that non-acid reflux may be associated with breathing problems in these young patients.

It is primarily used to treat chronic neuropathic pain. Since patients with chronic cough have a similar central sensitization to those with chronic neuropathic pain, the possible inhibition of hypersensitized cough center with gabapentin may be a new therapy for the refractory chronic cough. Ryan et al[49] have demonstrated that gabapentin can improve the cough symptoms and cough-specific quality of life in the patients with refractory chronic cough with 8-wk treatment with gabapentin starting at 300 mg daily and titrating up to 1800 mg daily.


The tablets are best taken after meals (when the stomach is distended) and when lying down, both times when reflux is more likely to occur. Foam barriers are not often used as the first or only treatment for GERD. Rather, they are added to other drugs for GERD when the other drugs are not adequately effective in relieving symptoms. There is only one foam barrier, which is a combination of aluminum hydroxide gel, magnesium trisilicate, and alginate (Gaviscon). Pro-motility drugs work by stimulating the muscles of the gastrointestinal tract, including the esophagus, stomach, small intestine, and/or colon.

Second, by bedtime, a smaller and earlier meal is more likely to have emptied from the stomach than is a larger one. As a result, reflux is less likely to occur when patients with GERD lie down to sleep.

Recognizing that in patients with multiple reflux episodes and few symptoms the association may occur by chance, other authors have advocated using, in addition to the symptom index, a symptom sensitivity index. The symptom sensitivity index is defined as the percentage of reflux episodes associated with symptoms out of the total number of reflux episodes. A symptom sensitivity index greater than 10% would further strengthen the symptom association with reflux. have shown that intraesophageal acid exposure differs based on the level at which it is measured.

Weakly acidic reflux (B) is defined as a pH fall of at least 1 unit where the pH does not fall below 4, and a pH of 7 is the cut off between “weakly acidic” and “non-acid reflux”. Weakly alkaline reflux (C) is defined as a reflux episode during which nadir oesophageal pH does not drop below 7.

A chest radiograph was done to confirm the position of the catheter in those in whom manometry failed to identify the lower oesophageal sphincter position. The bottom sensor was placed 5 cm above the oesophogogastric junction. Patients were then advised to continue with their usual daily activities, including eating and drinking as normal for 24 hours. The monitor was then retrieved after 24 hours of recording.

In these circumstances the decision to test the patient on or off therapy becomes difficult because, on the one hand, esophageal pH testing is more accurate when performed off therapy, but, on the other hand, esophageal pH testing cannot exclude nonacid reflux in patients. In our opinion combined MII-pH will overcome this impasse using the algorithm depicted in Figure 10 in evaluating patients with GERD symptoms. described reflux esophagitis in 1946, the armamentarium of clinically available tools to diagnose GERD has become more sophisticated as new technologies and approaches have been introduced. This has been fueled by the need to investigate the nature of esophageal symptoms (heartburn, regurgitation, dysphagia, chest pain, etc.) in the absence of endoscopic evidence of esophageal mucosal lesions and more recently to understand the causes of persistent esophageal symptoms in patients on potent acid suppressive therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *